RDMD Co-Founders to Participate in Upcoming Rare Disease and Health Technology Conferences
Summary
SAN FRANCISCO--(BUSINESS WIRE)--RDMD, a healthcare technology company dedicated to accelerating research for patients with rare diseases, today announced key leadership members will be participating in the following upcoming industry events this fall: ● Technology & Rare Neurological Diseases Symposium (TRNDS), being held Friday, September 13 in Rochester, NY. RDMD co-founder Onno Faber will give a talk about his journey as a citizen scientist and patient advocate; and, ● Duke Margolis Center for Health Policy’s 3rd Annual Conference on Real-world Data and Evidence, titled, “Developing Real-World Data and Evidence to Support Regulatory Decision-Making” at the National Press Club in Washington, D.C. on Thursday, October 3. RDMD is a healthcare technology company dedicated to accelerating drug development for patients with rare diseases. RDMD was co-founded by Onno Faber, following his diagnosis and journey with the rare disease neurofibromatosis type 2, and Nancy Yu, former head of corporate development at 23andMe. The company is backed by Lux Capital, Village Global, First Rounds Healthcare Co-Op and a number of angel investors.